Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer
48-Hour Crisis Action Plan: Prioritizing Patients, Ethics, and Sustainable Trust Core Principle: Patient safety is non-negotiable. Delaying action based on financial fear risks catastrophic legal liability, irreversible reputational damage, regulatory wrath, and profound ethical failure.Read the full answer